Skip to main navigation Skip to search Skip to main content

Researchers from University of Colorado Discuss Findings in Pancreatic Cancer (Survival after neoadjuvant and induction FOLFIRINOX versus gemcitabine-nab-paclitaxel in patients with resected localised pancreatic adenocarcinoma: an international ...)

Press/Media

Period13 Mar 2026

Media coverage

1

Media coverage

  • TitleResearchers from University of Colorado Discuss Findings in Pancreatic Cancer (Survival after neoadjuvant and induction FOLFIRINOX versus gemcitabine-nab-paclitaxel in patients with resected localised pancreatic adenocarcinoma: an international ...)
    Media name/outletNewsRx Drug Daily
    Country/TerritoryUnited States
    Date13/03/26
    PersonsNancy Miller